XML 32 R5.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Total revenue $ 170,155,000 $ 227,043,000 $ 251,455,000
Costs and operating expenses:      
Research and development 243,773,000 424,061,000 580,621,000
General and administrative 183,290,000 246,161,000 385,025,000
Impairment of lease assets 0 0 96,210,000
Goodwill impairment 0 47,858,000 0
Restructuring charges 11,398,000 24,172,000 0
Total operating expenses 485,433,000 786,800,000 1,115,861,000
Loss from operations (315,278,000) (559,757,000) (864,406,000)
Other income (expense):      
Interest income 22,616,000 38,612,000 57,217,000
Interest expense 0 (94,000) (93,000)
Loss on equity method investments 0 0 (2,635,000)
Loss on investments (16,411,000) (28,827,000) (54,827,000)
Loss on deconsolidation of subsidiaries 0 (7,013,000) (42,502,000)
Change in fair value of warrant liabilities 0 5,701,000 5,168,000
Other (expense) income, net (4,527,000) 3,870,000 9,138,000
Total other income (expense) 1,678,000 12,249,000 (28,534,000)
Loss before income taxes (313,600,000) (547,508,000) (892,940,000)
Income tax benefit (837,000) (479,000) (71,000)
Net loss $ (312,763,000) $ (547,029,000) $ (892,869,000)
Earnings Per Share [Abstract]      
Basic (in dollars per share) $ (5.64) $ (10.54) $ (18.37)
Diluted (in dollars per share) $ (5.64) $ (10.54) $ (18.37)
Weighted Average Number of Shares Outstanding, Basic [Abstract]      
Basic (in shares) 55,457,676 51,894,639 48,610,507
Weighted average common shares outstanding, diluted (in shares) 55,457,676 51,894,639 48,610,507
Comprehensive loss:      
Net loss $ (312,763,000) $ (547,029,000) $ (892,869,000)
Other comprehensive income (loss):      
Foreign currency translation adjustment 3,531,000 (4,782,000) 4,116,000
Reclassification of foreign currency translation adjustment realized upon sale of foreign subsidiary 0 1,492,000 0
Unrealized gain on available-for-sale securities (126,000) 0 0
Total other comprehensive income (loss) 3,657,000 (3,290,000) 4,116,000
Comprehensive loss (309,106,000) (550,319,000) (888,753,000)
Cell Engineering      
Total revenue [1] 132,746,000 173,972,000 143,531,000
Service      
Total revenue 37,409,000 53,071,000 78,975,000
Costs and operating expenses:      
Cost of revenue 31,521,000 38,549,000 46,524,000
Product      
Total revenue 0 0 28,949,000
Costs and operating expenses:      
Cost of revenue 0 0 7,481,000
Other      
Costs and operating expenses:      
Cost of revenue $ 15,451,000 $ 5,999,000 $ 0
[1] Includes related party revenue of $8,784, $53,041, and $22,222 for the years ended December 31, 2025, 2024, and 2023, respectively.